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Introduction
2
3Therefore, identification of markers for LCSCs as well as signaling pathways 
activated in LCSCs could advance the development of liver cancer diagnosis 
and treatment strategies.
iNOS/NO promotes Notch1 activation through TACE/ADAM17 activation in liver cancer 
stem cells (LCSCs), leading to a more aggressive cancer phenotype.
Hypothesis
4
ADAM: A Disintegrin and Metalloprotease 
TACE: TNFα-Converting Enzyme
5Results
CD24+CD133+ HCC cells possess stem/progenitor cell characteristics.
CD133+CD24+ cells would contribute to the progression of HCC 
6iNOS-Directed CD24+CD133+ HCC Cell Tumor Initiation and Self-Renewal 
Capacity in Vitro and in Vivo .
7iNOS Promotes the CSC Phenotype and Tumorigenicity via Activating Notch1 
NECD: Notch Extracellular Domain
NICD: Notch Intercellular Domain 
8iNOS Required TACE/ADAM17 to Activate Notch Signaling in LCSCs.
1400w: iNOS inhibitor
TAPI-2: TNF protease inhibitor 2
9TACE Binds to iRhom2 and Activates Notch Signaling in LCSCs in an 
iNOS/cGMP/PKG-Dependent Manner 
iRhom2: inactive rhomboid protein 2
ODQ : cGC inhibitor
KT5823 : PKG inhibitor 
Br-PET-cGMP :A non-hydrolyzable cGMP analog and potent activator of PKG 
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Elevated iNOS Expression Is Associated with Poor Prognosis in Patients with HCC 
and Positively Correlated with TACE and Notch1 Levels.
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